CDC Home

Cancer Screening — United States, 2010

Each year, approximately 350,000 persons are diagnosed with breast, cervical, or colorectal cancer in the United States, and nearly 100,000 die from these diseases (1). The U.S. Preventive Services Task Force (USPSTF) recommends screening tests for each of these cancers to reduce morbidity and mortality (2). Healthy People 2020 sets national objectives for use of the recommended cancer screening tests and identifies the National Health Interview Survey (NHIS) as the means to measure progress. Data from the 2010 NHIS were analyzed to assess use of the recommended tests by age, race, ethnicity, education, length of U.S. residence, and source and financing of health care to identify groups not receiving the full benefits of screening and to target specific interventions to increase screening rates. Overall, the breast cancer screening rate was 72.4% (below the Healthy People 2020 target of 81.1%), cervical cancer screening was 83.0% (below the target of 93.0%), and colorectal cancer screening was 58.6% (below the target of 70.5%). Screening rates for all three cancer screening tests were significantly lower among Asians than among whites and blacks. Hispanics were less likely to be screened for cervical and colorectal cancer. Higher screening rates were positively associated with education, availability and use of health care, and length of U.S. residence. Continued monitoring of screening rates helps to assess progress toward meeting Healthy People 2020 targets and to develop strategies to reach those targets.

NHIS is a periodic, nationwide, household survey of a representative sample of the U.S. civilian noninstitutionalized population; it includes cancer screening questions on the adult questionnaire. Respondents are asked whether they have been screened with specific tests for cancer, and if they have, when the tests were performed last. For this analysis, because the questionnaire did not distinguish between tests for screening and those performed for other reasons, any report of testing for cancer was categorized as a screening test. Reports of screening were used to determine the portion of the population up-to-date for screenings recommended by USPSTF (2).

Since 2006, NHIS has oversampled Hispanic and Asian populations (3), increasing the ability to examine screening use among specific racial and ethnic subgroups. Asians were categorized as Chinese, Filipino, or other Asian. Hispanics were categorized as Puerto Rican, Mexican, Mexican-American, Central or South American, or other Hispanic. Sampling weights were applied to account for the probability of selection. Screening percentages and 95% confidence intervals (CIs) were calculated using statistical software to account for complex sample design. Linear trends during 2000–2010 were tested for men and women separately using unadjusted logistic regression models. The conditional response rate for the 2010 NHIS adult sample was 77.3%, and the final response rate was 60.8% (3).

Breast Cancer Screening

USPSTF recommends that women aged 50–74 years be screened for breast cancer by mammography every 2 years (2). Based on responses to the 2010 NHIS, 72.4% (CI = 70.7%–74.0%) of women overall followed this recommendation, significantly less than the Healthy People 2020 target of 81.1% (4), with whites and blacks more frequently screened than Asians (Table 1). Considerably lower mammography use was reported by those reporting no usual source of health care (36.2%) or no health insurance (38.2%). Immigrant women who had been in the United States for ≥10 years were almost as likely as U.S.-born women to report having had a mammogram within the past 2 years (70.3% and 73.1%, respectively), whereas only 46.6% of immigrants in the United States for <10 years reported being screened in the past 2 years. Education level also was associated positively with screening. Overall, the proportion of women aged 50–74 years who reported having had a mammogram in the past 2 years remained stable during 2000–2010 (Figure).

Cervical Cancer Screening

USPSTF recommends that women aged 21–65 years with a cervix be screened for cervical cancer and precancerous lesions by Papanicolau (Pap) smear testing every 3 years (2). Overall, 83.0% (CI = 82.0%–84.0%) of women with no hysterectomy reported having a Pap test within the past 3 years (Table 1), significantly less than the Healthy People 2020 target of 93.0% (4). Rates were significantly lower among Asians (75.4% [CI = 71.1%–79.3%]). Among Asians, Filipinas were more likely to have been screened (86.9% [CI = 80.2%–91.6%]) than other Asians. Those without access to health care were less likely to receive testing; 64.9% of women with no usual source of care and 63.8% of uninsured women were up-to-date. From 2000 to 2010, a small but significant downward trend was observed in the number of women who reported having had a Pap test within the past 3 years.

Colorectal Cancer Screening

The USPSTF guidelines call for regular screening of both men and women for colorectal cancer, starting at age 50 years and continuing until age 75 years, by any of the following three regimens: 1) annual high-sensitivity fecal occult blood testing, 2) sigmoidoscopy every 5 years combined with high-sensitivity fecal occult blood testing every 3 years, or 3) screening colonoscopy at intervals of 10 years (2). Overall, 58.6% (CI = 57.3%–59.9%) of adults reported being up-to-date with colorectal cancer screening (Table 2). This is significantly lower than the Healthy People 2020 target of 70.5%. Nearly identical proportions of men (58.5%) and women (58.8%) reported being up-to-date. Whites were significantly more likely to report being up-to-date than blacks or Asians. Hispanics were less likely to report being up-to-date (46.5% [CI = 42.9%–50.2%]) than non-Hispanics. Among respondents who 1) had been in the United States for <10 years; 2) did not have a usual, nonemergency department source of care; or 3) did not have health insurance, less than a quarter reported having been screened within the recommended interval. Respondents aged 65–75 years were more likely to be up-to-date than those aged 50–64 years. Significant upward trends were seen in the proportion of adults up-to-date with colorectal cancer screening from 2000 to 2010 using any colorectal cancer screening regimen (Figure).

Reported by

Carrie N. Klabunde, PhD, Martin Brown, PhD, Rachel Ballard-Barbash, MD, National Cancer Institute. Mary C. White, ScD, Trevor Thompson, Marcus Plescia, MD, Div of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion; Sallyann Coleman King, MD, EIS Officer, CDC. Corresponding contributor: Sallyann Coleman King, scolemanking@cdc.gov, 770-488-5892.

Editorial Note

Measuring use of recommended cancer screening regimens and changes in use over time is important to identify groups that might not be receiving the full benefits of screening. The population-based estimates in this report show a slight downward trend in the proportion of women up-to-date with screening for cervical cancer but no change over time in breast cancer screening rates. Screening rates for colorectal cancer increased markedly for men and women, with the rate for women increasing slightly faster, so that rates among men and women were the same in 2010. Breast cancer and colorectal cancer screening rates for persons living in the United States <10 years have declined since 2008 (5,6), and many of those known to face health disparities, such as those without a source of health care and those who are uninsured, continue to be screened less often than recommended. The proportions of women being screened for breast cancer (72.4%) and cervical cancers (83.0%) are below the respective Healthy People 2020 targets of 81.1% and 93.0%. Screening for colorectal cancer has increased over time, reaching 58.6%, according to the 2010 NHIS data, and 65.4%, according to 2010 Behavioral Risk Factor Surveillance Survey (BRFSS) data (7). Both estimates are considerably lower than the Healthy People 2020 target of 70.5% (4). Differences between BRFSS and NHIS estimates of cancer screening rates are likely the result of differences in the methods used for the surveys (8).

Financial barriers to screening might explain some of the observed disparities in cancer screening rates. The National Breast and Cervical Cancer Early Detection Program provides free or low-cost screening and diagnostic breast and cervical cancer services to low-income, underinsured, and uninsured women, and access to state Medicaid programs for treatment if breast or cervical cancer are diagnosed.* The Affordable Care Act is expected to reduce financial barriers to screening by expanding insurance coverage. Breast, cervical, and colorectal cancer screening are now covered free in Medicare and in newly offered private insurance plans. State Medicaid programs that provide these services free will receive an enhanced federal match rate. Other efforts are needed, such as developing systems that identify persons eligible for cancer screening tests, actively encouraging the use of screening tests, and monitoring participation to improve screening rates.

Previous studies have shown that racial and ethnic subgroups differ in cancer screening use (9,10). Large variations were seen between some subgroups. Subgroups that were more likely to receive one type of cancer screening were not necessarily more likely to receive all types. This study further illustrates the importance of identifying and tracking differences among racial and ethnic subgroups and provides guidance for future targeted interventions.

The age ranges examined in this report correspond to the specifications in Healthy People 2020 objectives, based on current guidelines from USPSTF (2,3), but some persons younger or older than those ages also might benefit from screening. For cervical cancer screening, USPSTF recommends screening women aged >65 years who previously have not been screened or for whom information about previous screening is not available. For adults aged 75–85 years who previously have not been screened for colorectal cancer, USPSTF recommends that screening decisions be made considering the person's health status and competing risks. For mammography screening, USPSTF states that evidence is insufficient to assess the additional benefits and harms of screening in women aged ≥75 years.

The findings in this report are subject to at least four limitations. First, NHIS data are self-reported, and any report of testing for cancer was classified as a screening test; therefore, these data are subject to inaccuracies. Second, screening recommendations have changed over time. Third, before 2005, the NHIS survey allowed incomplete responses to questions about the date of the test, often requiring assumptions to recode screening measures. To facilitate comparisons over time, this analysis imposed the 2000 method, which allows use of data defined consistently across all years. As a result, the description of screening rates might be less accurate, so that the percentages shown for 2010 in the trend analysis differ slightly from those reported in the tables (5). Finally, the 2003 NHIS did not include questions on prior hysterectomy; consequently, 2003 data for Pap smears in the trend analysis were excluded to allow for exclusion of women who had undergone hysterectomy.

Although progress toward achieving the Healthy People 2020 objective for colorectal cancer screening is being made, screening for breast cancer and cervical cancer has not increased over the past decade, and screening use remains low for many groups. This study shows the disparity in subgroup screening rates. Monitoring of these groups is important to assess progress toward reaching Healthy People 2020 cancer screening targets. Efforts should be made to improve screening rates in all population groups (including targeted efforts for populations with particularly low levels of cancer screening).

References

  1. Taplin S. Breast cancer screening improvement means considering the entire process. Testimony before the Subcommittee on Health, Committee on Energy and Commerce, US House of Representatives; October 7, 2009. Washington, DC: US Department of Health and Human Services; 2011. Available at http://www.hhs.gov/asl/testify/2009/10/t20091007a.html. Accessed January 17, 2012.
  2. US Preventive Services Task Force. Recommendations for adults: cancer. Rockville, MD: US Preventive Services Task Force; 2011. Available at http://www.uspreventiveservicestaskforce.org/adultrec.htm. Accessed January 17, 2012.
  3. National Center for Health Statistics. 2010 National Health Interview Survey (NHIS) public use data release: NHIS survey description. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2011. Available at ftp://ftp.cdc.gov/pub/health_statistics/nchs/dataset_documentation/nhis/2010/srvydesc.pdf. Accessed January 19, 2012.
  4. US Department of Health and Human Services. Healthy People 2020 topics and objectives: cancer. Washington, DC: US Department of Health and Human Services; 2011. Available at http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=5. Accessed January 17, 2012.
  5. Breen N, Gentleman JF, Schiller JS. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 2011;117:2209–18.
  6. Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR. Trends in colorectal cancer test use among vulnerable populations in the United States. Cancer Epidemiol Biomarkers Prev 2011;20:1611–21.
  7. CDC. Vital signs: colorectal cancer screening, incidence, and mortality—United States, 2002–2010. MMWR 2011;60:884–9.
  8. Raghunathan T, Xie D, Schenker N, et al. Combining information from two surveys to estimate county-level prevalence rates of cancer risk factors and screening. J Am Stat Assoc 2007;102:474–86.
  9. Miller BA, Chu KC, Hankey BF, Ries LA. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control 2008;19:227–56.
  10. Gorin SS, Heck JE. Cancer screening among Latino subgroups in the United States. Prev Med 2005;40:515–26.

* Additional information is available at http://www.cdc.gov/cancer/nbccedp.


What is already known on this topic?

Screening at certain ages detects breast, cervical, and colorectal cancer early and reduces morbidity and mortality. The Healthy People 2020 targets for breast, cervical, and colorectal cancer screening are 81.1%, 93.0%, and 70.5% of the targeted age groups.

What is added by this report?

Analysis of data from the 2010 National Health Interview Survey shows that the proportion of the U.S. population screened for cancer according to current recommendations remains below target levels. The proportions screened are 72.4% for breast cancer, 83.0% for cervical cancer, and 58.6% for colorectal cancer. Screening rates for breast cancer have changed little in the past 10 years, whereas rates for cervical cancer have decreased slightly, and rates for colorectal cancer have increased. Screening use varies with age group, race, ethnicity, education, access to health care, and length of U.S. residence.

What are the implications for public health practice?

Efforts should be made to improve screening rates in all population groups (including targeting populations with particularly low levels of cancer screening) to increase population screening levels to meet Healthy People 2020 targets and reduce cancer morbidity and mortality.


FIGURE. Percentage of men and women up-to-date on screening for breast, cervical, or colorectal cancer, by type of test, sex, and year — United States, 2000–2010

The figure shows the percentage of men and women up-to-date on screening for breast, cervical, or colorectal cancer, by type of test, sex, and year in the United States during 2000-2010. Overall, the proportion of women aged 50-74 years who reported having had a mammogram in the past 2 years remained stable during 2000-2010. A small but significant downward trend was observed in the number of women who reported having had a Pap test within the past 3 years. Significant upward trends were seen in the proportion of adults up-to-date with colorectal cancer screening from 2000 to 2010 using any colorectal cancer screening regimen.

Abbreviations: CRC = colorectal cancer; Pap = Papanicolaou.

* Among women aged 21–65 years with no hysterectomy.

Among women aged 50–74 years.

§ Among persons aged 50–75 years.

Alternate Text: The figure above shows the percentage of men and women up-to-date on screening for breast, cervical, or colorectal cancer, by type of test, sex, and year in the United States during 2000-2010. Overall, the proportion of women aged 50-74 years who reported having had a mammogram in the past 2 years remained stable during 2000-2010. A small but significant downward trend was observed in the number of women who reported having had a Pap test within the past 3 years. Significant upward trends were seen in the proportion of adults up-to-date with colorectal cancer screening from 2000 to 2010 using any colorectal cancer screening regimen.


TABLE 1. Breast and cervical cancer screening percentages, by demographic and access to care characteristics — National Health Interview Survey, United States, 2010

Characteristic

Breast cancer

Cervical cancer

Mammogram within 2 yrs*

Pap test within 3 yrs*

No. 

%

(95% CI) 

No. 

%

(95% CI) 

Overall

4,869

72.4

(70.7–74.0)

8,999

83.0

(82.0–84.0)

Race

White

3,690

72.8

(70.9–74.6)

6,543

83.4

(82.3–84.5)

Black/African American

852

73.2

(69.7–76.3)

1,626

85.0

(82.8–87.0)

American Indian/Alaska Native

54

69.4

(53.4–81.7)

97

78.7

(65.9–87.5)

Asian

258

64.1

(57.6–70.0)

685

75.4

(71.1–79.3)

Chinese

54

68.1

(53.4–80.0)

144

71.6

(62.2–79.5)

Filipino

72

62.1

(48.9–73.7)

175

86.9

(80.2–91.6)

Other Asian

132

63.5

(53.4–72.5)

366

70.6

(65.1–75.6)

Ethnicity

Non-Hispanic

4,200

72.7

(70.9–74.4)

7,021

83.8

(82.6–84.9)

Hispanic

669

69.7

(65.5–73.6)

1,978

78.7

(76.3–80.8)

Puerto Rican

86

74.3

(62.7–83.2)

216

85.5

(77.3–91.1)

Mexican

212

66.4

(59.0–73.1)

794

75.0

(70.9–78.6)

Mexican American

144

66.1

(55.1–75.6)

418

80.1

(74.6–84.6)

Central or South American

105

71.4

(60.7–80.2)

327

79.8

(74.4–84.3)

Other Hispanic

122

76.5

(69.5–82.3)

223

81.5

(75.1–86.4)

Age group (yrs)

21–30

 

2,392

84.1

(82.2–85.9)

31–40

 

2,309

84.7

(82.7–86.4)

41–50

 

2,018

82.5

(80.2–84.6)

51–65

 

2280

80.8

(78.8–82.6)

50–64

3,386

72.7

(70.7–74.5)

 

 

65–74

1,483

71.9

(69.0–74.7)

 

 

Length of U.S. residence

U.S.-born

4,007

73.1

(71.3–74.8)

6,833

85.0

(83.9–86.0)

In United States <10 yrs

61

46.6

(33.5–60.2)

577

67.1

(62.3–71.5)

In United States ≥10 yrs

794

70.3

(66.6–73.8)

1,572

77.8

(74.6–80.7)

Education

Less than high school

809

58.3

(53.8–62.7)

1,244

69.4

(66.1–72.5)

High school graduate

1,375

69.5

(66.5–72.4)

2,010

77.7

(75.4–79.9)

Some college or associate degree

1,443

73.9

(71.1–76.4)

2,906

85.3

(83.6–86.8)

College graduate

1,229

80.8

(78.0–83.3)

2,818

89.0

(87.5–90.3)

Usual source of care

None or hospital emergency department

402

36.2

(30.3–42.4)

1,562

64.9

(61.7–67.9)

Has usual source

4,467

75.4

(73.7–77.0)

7,436

86.4

(85.4–87.4)

Health insurance

Private/Military

3,121

79.8

(77.9–81.5)

5,612

88.7

(87.7–89.7)

Public only

1,192

63.4

(59.8–66.9)

1,422

81.9

(79.1–84.4)

Uninsured

542

38.2

(33.5–43.2)

1,907

63.8

(61.1–66.4)

Abbreviations: CI = confidence interval; Pap = Papanicolaou.

* The U.S. Preventive Services Task Force recommends that women aged 50–74 years be screened for breast cancer by mammography every 2 years and that women aged 21–65 years be screened for cervical cancer and precancerous lesions by Pap smear testing every 3 years.

Overall percentages were age-standardized to the 2000 U.S. standard population. 


TABLE 2. Colorectal cancer screening percentages, by demographic and access to care characteristics — National Health Interview Survey, United States, 2010

Characteristic 

Colorectal cancer* 

No.

%

(95% CI) 

Overall

8,914

58.6

(57.3–59.9)

Sex

Male

3,929

58.5

(56.6–60.4)

Female

4,985

58.8

(57.1–60.5)

Race

White

6,813

59.8

(58.4–61.2)

Black/African American

1,524

55.0

(51.7–58.2)

American Indian/Alaska Native

82

49.5

(35.3–63.8)

Asian

472

46.9

(41.7–52.2)

Chinese

92

41.3

(28.8–55.0)

Filipino

138

54.5

(44.2–64.3)

Other Asian

242

44.3

(36.5–52.4)

Ethnicity

Non-Hispanic

7,745

59.9

(58.5–61.3)

Hispanic

1,169

46.5

(42.9–50.2)

Puerto Rican

147

55.3

(45.2–65.0)

Mexican

389

37.8

(31.9–44.1)

Mexican American

242

54.9

(47.2–62.3)

Central or South American

198

47.3

(39.3–55.5)

Other Hispanic

193

46.0

(36.7–55.5)

Age group (yrs)

50–64

6,091

55.0

(53.4–56.6)

65–75

2,823

67.9

(65.9–69.8)

Length of U.S. residence

U.S.-born

7,369

60.5

(59.1–61.8)

In United States <10 yrs

111

21.3

(14.0–31.0)

In United States ≥10 yrs

1,424

49.5

(46.2–52.8)

Education

Less than high school

1,521

44.6

(41.5–47.7)

High school graduate

2,472

53.6

(51.4–55.9)

Some college or associate degree

2,513

62.0

(59.8–64.1)

College graduate

2,376

67.3

(65.0–69.5)

Usual source of care

None or hospital emergency department

871

20.8

(17.4–24.6)

Has usual source

8,042

62.4

(61.1–63.7)

Health insurance

8,891

58.7

(57.4–60.0)

Private/Military

5,780

65.0

(63.4–66.5)

Public only

2,092

55.3

(52.5–58.1)

Uninsured

1,019

20.7

(17.9–23.8)

Abbreviation: CI = confidence interval.

* The U.S. Preventive Services Task Force recommends regular screening for colorectal cancer by men and women aged 50–75 years by 1) annual high-sensitivity fecal occult blood testing, 2) sigmoidoscopy every 5 years combined with high-sensitivity fecal occult blood testing every 3 years, or 3) screening colonoscopy at intervals of 10 years.

Overall percentages were age-standardized to the 2000 U.S. standard population. 


Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #